Clinical Trials Logo

Clinical Trial Summary

Evaluation of the HEMOTAG® system in a less controlled environment and concurrently develop the system for use by patients with heart failure.


Clinical Trial Description

The overall objective of research is to test, adapt, refine and validate the HEMOTAG® system to be used outside the usual medical care environments to reduce hospital readmissions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04149743
Study type Interventional
Source Aventusoft, LLC.
Contact Cindy Kober
Phone 561-945-9303
Email cindy@aventusoft.com
Status Recruiting
Phase N/A
Start date January 31, 2022
Completion date March 2024

See also
  Status Clinical Trial Phase
Completed NCT03456856 - A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction. Phase 4
Completed NCT03901729 - A Trial to Study BAY1753011 in Patients With Congestive Heart Failure Phase 2
Completed NCT02301689 - SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register
Completed NCT04915118 - A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF
Completed NCT02200822 - Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients Phase 4
Recruiting NCT05652218 - REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT) N/A
Completed NCT02127307 - Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up. N/A
Completed NCT01936649 - Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView. Phase 4